BLOODLESS MANAGEMENT OF ANAEMIC HIV – INFECTED PATIENTS IN SOUTH- SOUTH, NIGERIA.
DOI:
https://doi.org/10.53555/nnmhs.v6i6.877Keywords:
Anaemia, Human Immunodeficiency Virus (HIV), Blood transfusion, Bloodless Medicine, Surgery (BMS).Abstract
This is a prospective study that aimed at comparing patients’ morbidity and mortality among severely anaemic HIVpatients who were transfused and those who were no transfused. Anaemia is a common presentation among patients with human immunodeficiency virus infection. We treated 13 patients who had packed cell volume ≥ 20% and were randomized into two groups: group A had blood transfusion while group B did not. Other treatments such as haematinics, antihelminthics, antibiotics, treatment of opportunistic infections, no infusion and balanced nutrition were given to them. The survival rate was higher among those who did not receive blood transfusion while those who were transfused had higher mortality rate. The study concluded that bloodless management of severely anaemic HIV- patients with PCV ≥ 20% without blood transfusion had higher survival rate than those who were transfused.
References
Volberg PA, Levine AM, Dieterich D, Mildan D, Mitzsuyasu R, Saag M. Anaemia in HIV infection : Clinical Impact and Evidenced –Based Management Strategies. Clinical Infect. Dis. 2004; 38(10)1454-1463.
Hebert PC, Wells G, Blacjchman MA, et al. A multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. Transfusion requirements in clinical care investigators, Canadian critical care trial Group. N Engl Med. 1999; 340:409-417.
Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer Recurrence and Infection. Archpathol. Lab. Med. 1994; 118:371-379.
Lum E. Kimbi H, Onyoh E. Bessong P.et al. The Impact of HIV and Plasmodium Falciparium genetic Diversity on anaemia in HIV –patients Attending Care and Treatment Centre at Baptist Hospital, Mutengene . International Journal of Research Studies in Bioscience.2016; 4(5): 26-37.
Bhusal RR, Devkota S, Shrestha M, Khadga P. Profile of Anaemia in HIV Positive Patients. JCMS Nepal. 2016,12(2):70-73.
Ford P, Mastoris J, Badani K, Columbus M. Profitability of Medical Procedures without the use of Transfusion Support. Blood. 2004; 104:5316.
Engoren MC, Habib RH, Zacharias A, Schwan TA, Riordan CJ, Durham SJ. Effect of Blood Transfusion on Longterm Survival after Cardiac Operation. Ann. Thorac Surg. 2002; 74:1180-1186.
Claster S. Biology of Anaemia , Different Diagnosis and Treatment Options in Human Immunodeficiency Virus Infection. J. infect. Dis. 2002;185(2): 5105-5109.
Sullivan P. Association of Anaemia , Treatments for Anaemia , and Survival in Patients with Human Immunodeficiency Virus Infection. J. Infect. Dis.2002; 185(2):138-142.
Volberding P. The impact of anaemia on Quality of life in Human Immunodeficiency Virus – infected Patients. J. Infect. Dis.2002;185(2):5110-4
Akiwu U. Nutritional Intake of People Living with HIV/AIDS in Rural Communities of Benue State, Nigeria. Journal of Agriculture and food sciences. 2018; 16(2):88-99.
Llewellyn CA, Heritt PE, Knight RS, et al .Possible Transfusion of Variant CreutzfeldtJacob blood Transfusion. Lancet. 2004:363:417-412.
Ferri RS, Adinolfia A, Orsi DJ, Keruly JC, Davis S, Machtyre RC. Treatment of Anaemia in Patients with HIVinfection ..Part 2:Guidelines for management of Anaemia. J. Assoc. Nurses AIDS . 2002;13(1):50-59.
Levine BJ. Anaemia in the Setting of Cancer and Human Immunodeficiency Virus. Clin. Infect. Dis.2003;37(4):5304-5314
Bhaisara BB, Gaire M, Manglani M, Wade M, Shorma S. Impact of Anaemia on Outcome of HIV Infected Paediatric Patients: A Prospective Observational Study. Indian J. Community Medicine. 2019; 44(2):152-156.
Bain BJ. Pathogenesis and Pathophysiology in HIV Infection. Curr Open Haematol. 1999;6(2):89-93.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
